Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1d24dc44e2780127ca4c3e6db039e6f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2020-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e584b788e64f388927d8af2be23c1c16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb8bec40c04d0d0b7d18ba1ff6ee2769 |
publicationDate |
2021-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20210111389-A |
titleOfInvention |
Sustained-release formulation of macrolide antibiotics with improved stability in the gastrointestinal tract |
abstract |
The present invention relates to a formulation of a pharmaceutical composition for extended release of a macrolide antibiotic in the gastrointestinal environment, the formulation comprising a therapeutically effective amount of a macrolide antibiotic and a pharmaceutically acceptable stabilizer and release controlling agent. , it can keep the drug stable even at low pH in the gastrointestinal tract. |
priorityDate |
2020-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |